This report is provided by MacroTerms.com
Data as of: 2026-10-23 · Settlement: Exchange final daily settlement
Corn (ZC=F) Deep Dive | Bearish Bias | 2026-10-25
We stay SHORT ZCZ26.CBT corn. The continuous contract maps to the December 2026 CBOT delivery (ZCZ26.CBT); settlement is 456 [settle 2026-10-23], down 13.68% over 20 sessions, with ATR14 at 10.14 (2.22% of price) and RV20 at 22.6% confirming a persistent, high-volatility downtrend rather than a stable base. Three factors drive the call: first, price has closed lower in each of the last five settled sessions (467 → 462 → 463.25 → 460.5 → 456) and sits at the bottom of the 20-day range ex-today of 453.5–529, only 2.5 cents above the range low; second, the term structure shows a deep M1–M2 contango of −14.25 (−3.03%) with a roll yield of −12.12%, meaning long positions pay a negative carry while the spot premium erodes — a classic signature of ample physical supply and weak nearby demand; third, seasonality over the next 20 sessions is negative on average (mean −1.02%, median −1.17%, up only 6 of 15 years), and the macro backdrop of a firm dollar (DXY 101.81) plus a 10Y yield near 4.99% is a headwind for dollar-priced export demand. Invalidation is a daily settle above the next-session pivot at 457.83; a decisive break below 453.42 (S1) targets 450.83 (S2), roughly 0.5×ATR beyond the trigger. No Asia print was captured for this report date, so intraday levels are not quoted.
This brief is published in Chinese. The English translation is being prepared.
Today's Risk Map
Macro · Micro · Cross-assetVIP members unlock thresholds & transmission chains. Upgrade
Full brief is for VIP members
The body, key levels, charts and PDF are for active VIP members.
Single-name briefs Deep dive
Previous briefs
⟠ This month's strategy backtest
Daily AI brief ideas settled day-by-day with objective stop/target matching
No settled signals yet - sample building up.
* Backtest settles each daily trade idea: stop/target whichever first, flat at close when window ends. Past performance does not predict future results.